|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/17 | |
| A61K 38/16 | |||
| A61K 48/00 | |||
| A61P 35/00 |
| (11) | Number of the document | 2809338 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12842939.6 |
| Date of filing the European patent application | 2012-10-26 | |
| (97) | Date of publication of the European application | 2014-12-10 |
| (45) | Date of publication and mention of the grant of the patent | 2020-02-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/062241 |
| Date | 2012-10-26 |
| (87) | Number | WO 2013/063482 |
| Date | 2013-05-02 |
| (30) | Number | Date | Country code |
| 201161553090 P | 2011-10-28 | US |
| (72) |
SHAH, Neil Pravin, US
SMITH, Catherine Choy, US
|
| (73) |
The Regents of the University of California,
1111 Franklin Street, 12th Floor, Oakland, CA 94607,
US
|
| (54) | FLT3 MUTATIONS ASSOCIATED WITH DRUG RESISTANCE IN AML PATIENTS HAVING ACTIVATING MUTATIONS IN FLT3 |
| FLT3 MUTATIONS ASSOCIATED WITH DRUG RESISTANCE IN AML PATIENTS HAVING ACTIVATING MUTATIONS IN FLT3 |